Caricamento...
Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are major contributors to the burden of liver disease today. Effective therapeutic strategies for prevention of progression of NASH to cirrhosis are still elusive. As with other diseases causing cirrhosis, NASH also inc...
Salvato in:
| Pubblicato in: | J Clin Exp Hepatol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7527837/ https://ncbi.nlm.nih.gov/pubmed/33029058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2020.04.004 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|